Rebecca A HubbardSummaryAffiliation: Group Health Cooperative Country: USA Publications
| Collaborators
|
Detail Information
Publications
Diagnostic imaging and biopsy pathways following abnormal screen-film and digital screening mammographyRebecca A Hubbard
Group Health Research Institute, Group Health Cooperative, 1730 Minor Ave, Suite 1600, Seattle, WA, 98101, USA
Breast Cancer Res Treat 138:879-87. 2013..To guide health systems in their efforts to eliminate practices that do not contribute to effective care, we need further research to identify the causes of this variation and the best evidence-based approach for follow-up...
Effects of digital mammography uptake on downstream breast-related care among older womenRebecca A Hubbard
Group Health Research Institute, Group Health Cooperative, Department of Biostatistics, School of Public Health, University of Washington, Seattle, WA, USA
Med Care 50:1053-9. 2012..Digital mammography is the dominant modality for breast cancer screening in the United States. No previous studies have investigated as to how introducing digital mammography affects downstream breast-related care...
Modelling the cumulative risk of a false-positive screening testRebecca A Hubbard
Group Health Research Institute, Biostatistics Unit and Department of Biostatistics, University of Washington, Seattle, WA 98101, USA
Stat Methods Med Res 19:429-49. 2010..The estimated risk of an FP recall after 10 screening mammograms varied between 58% and 77% depending on the approach used, with an estimate of 63% based on what we feel are the most reasonable modelling assumptions...
Cumulative probability of false-positive recall or biopsy recommendation after 10 years of screening mammography: a cohort studyRebecca A Hubbard
Group Health Cooperative and School of Public Health of the University of Washington, Seattle, USA
Ann Intern Med 155:481-92. 2011..False-positive mammography results are common. Biennial screening may decrease the cumulative probability of false-positive results across many years of repeated screening but could also delay cancer diagnosis...
Oral contraceptive use and bone density change in adolescent and young adult women: a prospective study of age, hormone dose, and discontinuationDelia Scholes
Group Health Research Institute, Group Health Cooperative, 1730 Minor Avenue, 16th Floor, Seattle, Washington 98101, USA
J Clin Endocrinol Metab 96:E1380-7. 2011..Oral contraceptive (OC) use is common, but bone changes associated with use of contemporary OC remain unclear...
